1. 1Dana Farber/Boston Children’s Cancer and Blood Disorders Center, Boston, MA;
2. 2Department of Pediatrics, Harvard Medical School, Boston, MA;
3. 3Division of Hematology/Oncology, Nationwide Children’s Hospital, Columbus, OH;
4. 4Department of Pediatrics, The Ohio State University School of Medicine, Columbus, OH;
5. 5Translational Medicine, The Hospital for Sick Children, Toronto, ON, Canada;
6. 6Department of Kinesiology and Physical Education, University of Toronto, Toronto, ON, Canada;
7. 7Division of Clinical Therapies, Nationwide Children’s Hospital, Columbus, OH;
8. 8Division of Hematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada;
9. 9Research Institute, The Hospital for Sick Children, Cell Biology Program, Toronto, ON, Canada;
10. 10Center for Clinical and Translational Research, Abigail Wexner Research Institute, Columbus, OH;
11. 11Division of Hematology, Cincinnati Children’s Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH;
12. 12Division of Pediatric Hematology/Oncology, UH Rainbow Babies and Children’s Hospital, Cleveland, OH;
13. 13Research Institute, The Hospital for Sick Children, Translational Medicine Program, Toronto, ON, Canada;
14. 14Department of Pathology and Molecular Medicine, Queens University, Kingston, ON, Canada; and
15. 15Research Institute, The Hospital for Sick Children, Child Health Evaluative Sciences, Toronto, ON, Canada